UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prevalence and management of chronic kidney disease in primary care patients in the UK

International journal of clinical practice (Esher), 2014-09, Vol.68 (9), p.1110-1121

2014

Volltextzugriff (PDF)

LDL-C treatment gaps in statin-treated patients at high and very high cardiovascular risk in Europe

Atherosclerosis, 2014-08, Vol.235 (2), p.e106-e106

2014

Volltextzugriff (PDF)

Statin treated patients at very high cardiovascular risk in Europe: Are the majority close to LDL-C

Atherosclerosis, 2014-08, Vol.235 (2), p.e35-e35

2014

Volltextzugriff (PDF)

Low LDL-C target achievement among treated acs patients in germany: the dyslipidemia international study (dysis) iiacs results

Atherosclerosis, 2015-07, Vol.241 (1), p.e201-e202

2015

Volltextzugriff (PDF)

Impact of lipid-lowering therapy on the prevalence of dyslipidaemia in patients at high-risk of cardiovascular events in UK primary care - a retrospective database study

International journal of clinical practice (Esher), 2013-12, Vol.67 (12), p.1228-1237

2013

Volltextzugriff (PDF)

Prevalence of lipid abnormalities among treated ACS patients in Greece: The Dyslipidemia International Study (DYSIS) II ACS results

Atherosclerosis, 2015-07, Vol.241 (1), p.e130-e130

2015

Volltextzugriff (PDF)

LDL-C target attainment among treated ACS patients in Hong Kong and Taiwan: The Dyslipidemia International Study (DYSIS) II ACS results

Atherosclerosis, 2015-07, Vol.241 (1), p.e131-e131

2015

Volltextzugriff (PDF)

Lipid abnormalities remain high among diabetic patients with stable CHD: Results of the Dyslipidemia International Study (DYSIS) II Belgium

Atherosclerosis, 2015-07, Vol.241 (1), p.e130-e130

2015

Volltextzugriff (PDF)

LDL-C level and goal attainment among patients who switch from higher-efficacy lipid lowering therapies to simvastatin

Value in health, 2013-05, Vol.16 (3), p.A275-A275

2013

Volltextzugriff (PDF)

Prevalence of lipid abnormalities and attainment of normal lipid levels among patients with dyslipidaemia: a pooled analysis of observational studies from five Asian countries

International journal of clinical practice (Esher), 2014-08, Vol.68 (8), p.1010-1019

2014

Volltextzugriff (PDF)

PCV127 Time to Initiation of Oral Antihyperglycaemic and Statin Therapy in Patients with Newly Diagnosed Type 2 Diabetes Mellitus

Value in health, 2011, Vol.14 (7), p.A387-A387

2011

Volltextzugriff (PDF)

PND57 THE SOCIETAL BURDEN OF PRODROMAL ALZHEIMER’S DISEASE IN THE UNITED STATES

Value in health, 2019-05, Vol.22, p.S280-S280

2019

Volltextzugriff (PDF)

Cholesterol goal achievement and lipid-lowering therapy in patients with stable or acute coronary heart disease in Singapore: results from the Dyslipidemia International Study II

Singapore medical journal, 2019-09, Vol.60 (9), p.454-462

2019

Volltextzugriff (PDF)

PCV22 - LDL-C level and goal attainment among patients who switch from higher-efficacy lipid lowering therapies to simvastatin

Value in health, 2013-05, Vol.16 (3), p.A275-A275

2013

Volltextzugriff (PDF)

Prevalence of lipid abnormalities before and after introduction of lipid modifying therapy among Swedish patients with dyslipidemia (PRIMULA)

BMC public health, 2010-11, Vol.10 (1), p.737-737, Article 737

2010

Volltextzugriff (PDF)

Prevalence of lipid abnormalities before and after the introduction of lipid modifying therapy among Swedish patients with type 2 diabetes and/or coronary heart disease (PRIMULA Sweden)

Diabetologia, 2009, Vol.52 (Suppl. 1), p.S495

2009

Volltextzugriff (PDF)

Mixed dyslipidemias in primary care patients in France

Vascular health and risk management, 2012-01, Vol.8 (default), p.247-254

2012

Volltextzugriff (PDF)

Use of guideline-recommended treatments in 10,661 patients with coronary heart disease: Observational multinational DYSIS II study

Archives of Cardiovascular Diseases Supplements, 2018-01, Vol.10 (1), p.130-130

2018

Volltextzugriff (PDF)

Quality of Life of Patients with Alzheimer's Disease - A Comparison with General Population

Value in health, 2016-11, Vol.19 (7), p.A436-A436

2016

Volltextzugriff (PDF)

PND64 - Quality of Life of Patients with Alzheimer's Disease - A Comparison with General Population

Value in health, 2016-11, Vol.19 (7), p.A436-A436

2016

Volltextzugriff (PDF)

Economic and Humanistic Benefits of Maintaining Cognitive Impairment Patients in the Early Stage

Value in health, 2016-11, Vol.19 (7), p.A438-A438

2016

Volltextzugriff (PDF)

PND73 - Economic and Humanistic Benefits of Maintaining Cognitive Impairment Patients in the Early Stage

Value in health, 2016-11, Vol.19 (7), p.A438-A438

2016

Volltextzugriff (PDF)

PND71 - Comparison of Informal Caregiving Time Required by Alzheimer's Disease Patients and Mild Cognitive Impairment Patients

Value in health, 2016-11, Vol.19 (7), p.A437-A438

2016

Volltextzugriff (PDF)

ND1 Burden And Work Productivity Loss Impairment From Providing Care To Alzheimer's Disease Patients

Value in health, 2016-11, Vol.19 (7), p.A351-A351

2016

Volltextzugriff (PDF)

Comparison of Informal Caregiving Time Required by Alzheimer's Disease Patients and Mild Cognitive Impairment Patients

Value in health, 2016-11, Vol.19 (7), p.A437-A438

2016

Volltextzugriff (PDF)

1 – 25 von 74

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(63)

Publikationsform

Artikel
(74)

Sprache

Englisch
(74)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prevalence and management of chronic kidney disease in primary care patients in the UK

LDL-C treatment gaps in statin-treated patients at high and very high cardiovascular risk in Europe

Statin treated patients at very high cardiovascular risk in Europe: Are the majority close to LDL-C

Low LDL-C target achievement among treated acs patients in germany: the dyslipidemia international study (dysis) iiacs results

Impact of lipid-lowering therapy on the prevalence of dyslipidaemia in patients at high-risk of cardiovascular events in UK primary care - a retrospective database study

Prevalence of lipid abnormalities among treated ACS patients in Greece: The Dyslipidemia International Study (DYSIS) II ACS results

LDL-C target attainment among treated ACS patients in Hong Kong and Taiwan: The Dyslipidemia International Study (DYSIS) II ACS results

Lipid abnormalities remain high among diabetic patients with stable CHD: Results of the Dyslipidemia International Study (DYSIS) II Belgium

LDL-C level and goal attainment among patients who switch from higher-efficacy lipid lowering therapies to simvastatin

Prevalence of lipid abnormalities and attainment of normal lipid levels among patients with dyslipidaemia: a pooled analysis of observational studies from five Asian countries

PCV127 Time to Initiation of Oral Antihyperglycaemic and Statin Therapy in Patients with Newly Diagnosed Type 2 Diabetes Mellitus

PND57 THE SOCIETAL BURDEN OF PRODROMAL ALZHEIMER’S DISEASE IN THE UNITED STATES

Cholesterol goal achievement and lipid-lowering therapy in patients with stable or acute coronary heart disease in Singapore: results from the Dyslipidemia International Study II

PCV22 - LDL-C level and goal attainment among patients who switch from higher-efficacy lipid lowering therapies to simvastatin

Prevalence of lipid abnormalities before and after introduction of lipid modifying therapy among Swedish patients with dyslipidemia (PRIMULA)

Prevalence of lipid abnormalities before and after the introduction of lipid modifying therapy among Swedish patients with type 2 diabetes and/or coronary heart disease (PRIMULA Sweden)

Mixed dyslipidemias in primary care patients in France

Use of guideline-recommended treatments in 10,661 patients with coronary heart disease: Observational multinational DYSIS II study

Quality of Life of Patients with Alzheimer's Disease - A Comparison with General Population

PND64 - Quality of Life of Patients with Alzheimer's Disease - A Comparison with General Population

Economic and Humanistic Benefits of Maintaining Cognitive Impairment Patients in the Early Stage

PND73 - Economic and Humanistic Benefits of Maintaining Cognitive Impairment Patients in the Early Stage

PND71 - Comparison of Informal Caregiving Time Required by Alzheimer's Disease Patients and Mild Cognitive Impairment Patients

ND1 Burden And Work Productivity Loss Impairment From Providing Care To Alzheimer's Disease Patients

Comparison of Informal Caregiving Time Required by Alzheimer's Disease Patients and Mild Cognitive Impairment Patients

Suchergebnisse filtern